Search research articles
Contact Us
Filters
Showing results (131-140 of 237) with videos related to
Page
of 24
Sort By:
European Journal of Haematology
|
October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
Jens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Annals of Hematology
|
March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival
Sara Oubari, Maria Papathanasiou, Lars Michel, et al.
Bone Marrow Transplantation
|
June 20, 2020
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis
Lorenz Selberg, Peter Stadtherr, Sascha Dietrich, et al.
Clinical Transplantation
|
August 6, 2013
Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis
Clemens Franz, Katrin Hoffmann, Ulf Hinz, et al.
Cell Reports Methods
|
December 1, 2022
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma
Tobias Dittrich, Sebastian Köhrer, Martin Schorb, et al.
Ejhaem
|
December 5, 2022
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior-A case report
Simone Feurstein, Julian Zoller, Constantin Schwab, et al.
British Journal of Haematology
|
June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
European Journal of Haematology
|
May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursors
Katharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Cytometry. Part B, Clinical Cytometry
|
March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma
Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to S. Girnius et al
Giovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 237) with videos related to
Sort By:
Page
of 24
European Journal of Haematology
|
October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
Jens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Annals of Hematology
|
March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival
Sara Oubari, Maria Papathanasiou, Lars Michel, et al.
Bone Marrow Transplantation
|
June 20, 2020
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis
Lorenz Selberg, Peter Stadtherr, Sascha Dietrich, et al.
Clinical Transplantation
|
August 6, 2013
Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis
Clemens Franz, Katrin Hoffmann, Ulf Hinz, et al.
Cell Reports Methods
|
December 1, 2022
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma
Tobias Dittrich, Sebastian Köhrer, Martin Schorb, et al.
Ejhaem
|
December 5, 2022
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior-A case report
Simone Feurstein, Julian Zoller, Constantin Schwab, et al.
British Journal of Haematology
|
June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
European Journal of Haematology
|
May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursors
Katharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Cytometry. Part B, Clinical Cytometry
|
March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma
Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to S. Girnius et al
Giovanni Palladini, Angela Dispenzieri, Morie Gertz, et al.
Page
of 24